Is technology scouting draining resources?
Finding genuinely differentiated medical technologies early is increasingly difficult.
Deal flow is noisy, crowded with incremental innovation, and often lacks rigorous technical validation. Internal teams are stretched, while promising assets frequently sit outside traditional networks or geographies.
Hypothesis-driven technology scouting
We provide structured, hypothesis-driven technology scouting tailored to your investment thesis.
Drawing on deep MedTech domain expertise and global networks, we identify, screen, and prioritise technologies with true clinical relevance, regulatory feasibility, and commercial potential.
Our approach goes beyond surface-level landscaping �" we assess technology readiness, IP defensibility, development and market-access risks, and strategic fit before assets ever reach your IC.
Post-Investment Value Creation
Focus R&D and innovation on what will truly drive enterprise value.
Capital-Efficient Innovation
Prioritise programs and platforms with the highest strategic and commercial return.
Alignment from Lab to Exit
Ensure technical development supports market access, scale-up, and exit strategy.Book a discovery call
Book a free consultation to define your investment thesis and see how targeted technology scouting can strengthen your pipeline.
Not sure, it’s right for you? Browse our related resources and services below.
